Studies of Congenic Lines in the Brown Norway Rat Model of Th2-Mediated Immunopathological Disorders Show That the Aurothiopropanol Sulfonate-Induced Immunological Disorder (Aiid3) Locus on Chromosome 9 Plays a Major Role Compared to Aiid2 on Chromosome 10

Journal of Immunology

Volumn 172, Issue 10, 2004, Pages 6354-6361

  Mas, Magali ^a,d   Cavaillès, Pierre ^a   Colacios, Céline ^a   Subra, Jean François ^a,e   Lagrange, Dominique ^a   Calise, Maryline ^a   Christen, Marie Odile ^b   Druet, Philippe ^a   Pelletier, Lucette ^a   Gauguier, Dominique ^c   Fournié, Gilbert J ^a  

^a CHU PURPAN   (France)

^b Solvay Pharma   (France)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d INSTITUT PASTEUR   (France)

^e ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOCHRYSINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; BROWN NORWAY RAT; CHROMOSOME 10; CHROMOSOME 20; CHROMOSOME 9; CHROMOSOME MAP; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MODEL; DISEASE PREDISPOSITION; EXPERIMENTAL MODEL; GENE CONTROL; GENE FUNCTION; GENE LOCUS; GENE LOCUS AIID2; GENE LOCUS AIID3; GENETIC MARKER; GENOTYPE; GLOMERULOPATHY; GLOMERULUS; IMMUNE RESPONSE; IMMUNOPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RAT; RAT STRAIN; TH2 CELL;

EID: 2442427329     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.10.6354     Document Type: Article

References (44)

1. Fournié, G. J., B. Cautain, E. Xystrakis, J. Damoiseaux, M. Mas, D. Lagrange, I. Bernard, J.-F. Subra, L. Pelletier, P. Druet, et al. 2001. Cellular and genetic factors involved in the difference between Brown-Norway and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases, Immunol. Rev. 184:145.
2. Gasser, D. L., C. M. Newlin, J. Palm, and N. K. Gonatas. 1973. Genetic control of susceptibility to experimental allergic encephalomyelitis in rats. Science 181:872.
3. Toumade, H., J. C. Guery, R. Pasquier, M. C. Vial, C. Mandet, E. Druet, P. M. Dansette, P. Druet, and L. Pelletier. 1991. Effect of the thiol group on experimental gold-induced autoimmunity. Arthritis Rheum. 34:1594.
4. Grennan, D. M., and D. G. Palmer. 1979. Serum IgE concentrations in rheumatoid arthritis: lack of correlation with gold toxicity. Br. Med. J. 2:1477.
5. Empire Rheumatism Council. 1961. Gold therapy in rheumatoid arthritis-final report of a multi-centre controlled trial. Ann. Rheum. Dis. 20:315.
6. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. 1996. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum. 39:713.
7. Goldbach-Mansky, R., and P. E. Lipsky. 2003. New concepts in the treatment of rheumatoid arthritis. Annu. Rev. Med. 54:197.
8. Toumade, H., J. C. Guery, R. Pasquier, D. Nochy, N. Hinglais, B. Guilbert, P. Druet, and L. Pelletier. 1991. Experimental gold-induced autoimmunity. Nephrol Dial. Transplant. 6:621.
9. Kermarrec, N., C. Dubay, B. De Gouyon, C. Blanpied, D. Gauguier, K. Gillespie, P. W. Mathieson, P. Druet, M. Lathrop, and F. Hirsch. 1996. Serum IgE concentration and other immune manifestations of treatment with gold salts are linked to the MHC and IL4 regions in the rat. Genomics 31:111.
10. Mas, M., J. F. Subra, D. Lagrange, S. Pilipenko-Appolinaire, N. Kermarrec, D. Gauguier, P. Druet, and G. J. Fournie. 2000. Rat chromosome 9 bears a major susceptibility locus for IgE response. Eur. J. Immunol. 30:1698.
11. Rogner, U. C., and P. Avner. 2003. Congenic mice: cutting tools for complex immune disorders. Nat. Rev. Immunol. 3:243.
12. Olofsson, P., J. Holmberg, J. Tordsson, S. Lu, B. Akerstrom, and R. Holmdahl. 2003. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat. Genet. 33:25.
13. Rozzo, S. J., J. D. Allard, D. Choubey, T. J. Vyse, S. Izui, G. Peltz, and B. L. Kotzin. 2001. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15:435.
14. Aitman, T. J., A. M. Glazier, C. A. Wallace, L. D. Cooper, P. J. Norsworthy, F. N. Wahid, K. M. Al-Majali, P. M. Trembling, C. J. Mann, C. C. Shoulders, et al. 1999. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 21:76.
15. Rehbinder, C., P. Baneux, D. Forbes, H. van Herck, W. Nicklas, Z. Rugaya, and G. Winkler. 1996. FELASA recommendations for the health monitoring of mouse, rat, hamster, gerbil, guinea pig and rabbit experimental units: report of the Federation of European Laboratory Animal Science Associations (FELASA) Working Group an Animal Health accepted by the FELASA Board of Management, November 1995. Lab. Anim. 30:193.
16. Wakeland, E., L. Morel, K. Achey, M. Yui, and J. Longmate. 1997. Speed congenics: a classic technique in the fast lane (relatively speaking), Immunol. Today 18:472.
17. Bihoreau, M. T., D. Gauguier, N. Kato, G. Hyne, K. Lindpaintner, J. P. Rapp, M. R. James, and G. M. Lathrop. 1997. A linkage map of the rat genome derived from three F2 crosses. Genome Res. 7:434.
18. Jacob, H. J., D. M. Brown, R. K. Bunker, M. J. Daly, V. J. Dzau, A. Goodman, G. Koike, V. Kren, T. Kurtz, A. Lemmark, et al. 1995. A genetic linkage map of the laboratory rat, Ranus norvegicus. Nat. Genet. 9:63.
19. Watanabe, T. K., M. T. Bihoreau, L. C. McCarthy, S. L. Kiguwa, H. Hishigaki, A. Tsuji, J. Browne, Y. Yamasaki, A. Mizoguchi-Miyakita, K. Oga, et al. 1999. A radiation hybrid map of the rat genome containing 5,255 markers. Nat. Genet. 22:27.
20. Lander, E. S., P. Green, J. Abrahamson, A. Barlow, M. J. Daly, S. E. Lincoln, and L. Newburg. 1987. MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics 1:174.
21. Druet, E., F. Praddaude, P. Druet, and G. Dietrich. 1998. Non-immunoglobulin serum proteins prevent the binding of IgG from normal rats and from rats with Th2-mediated autoimmune glomerulonephritis to various autoantigens including glomerular antigens. Eur. J. Immunol. 28:183.
22. Frazer, K. A., Y. Ueda, Y. Zhu, V. R. Gifford, M. R. Garofalo, N. Mohandas, C. H. Martin, M. J. Palazzolo, J. F. Cheng, and E. M. Rubin. 1997. Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster region. Genome Res. 7:495.
23. Noguchi, E., Y. Nukaga-Nishio, Z. Jian, Y. Yokouchi, M. Kamioka, K. Yamakawa-Kobayashi, H. Hamaguchi, A. Matsui, M. Shibasaki, and T. Arinami. 2001. Haplotypes of the 5′ region of the IL-4 gene and SNPs in the intergene sequence between the IL-4 and IL-13 genes are associated with atopic asthma. Hum. Immunol. 62:1251.
24. Lacy, D. A., Z. E. Wang, D. J. Symula, C. J. McArthur, E. M. Rubin, K. A. Frazer, and R. M. Locksley. 2000. Faithful expression of the human 5q31 cytokine cluster in transgenic mice. J. Immunol. 164:4569.
25. Gorham, J. D., M. L. Guler, R. G. Steen, A. J. Mackey, M. J. Daly, K. Frederick, W. F. Dietrich, and K. M. Murphy. 1996. Genetic mapping of a murine locus controlling development of T helper I/T helper 2 type responses. Proc. Natl. Acad. Sci. USA 93:12467.
26. Guler, M. L., J. D. Gorham. W. F. Dietrich, T. L. Murphy, R. G. Steen, C. A. Parvin, D. Fenoglio, A. Grupe, G. Peltz, and K. M. Murphy. 1999. Tpm1, a locus controlling IL-12 responsiveness, acts by a cell-autonomous mechanism. J. Immunol. 162:1339.
27. Meyers, D. A., D. S. Postma, C. I. Panhuysen, J. Xu, P. J. Amelung, R. C. Levitt, and E. R. Bleecker. 1994. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 23:464.
28. Marsh, D. G., J. D. Neely, D. R. Breazeale, B. Ghosh, L. R. Freidhoff, E. Ehrlich-Kautzky, C. Schou, G. Krishnaswamy, and T. H. Beaty. 1994. Linkage analysis of ILA and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264:1152.
29. Walley, A. J., S. Wiltshire, C. M. Ellis, and W. O. Cookson. 2001. Linkage and allelic association of chromosome 5 cytokine cluster genetic markers with atopy and asthma associated traits. Genomics 72:15.
30. Margolis, B., P. Hu, S. Katzav, W. Li, J. M. Oliver, A. Ullrich, A. Weiss, and J. Schlessinger. 1992. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motif. Nature 356:71.
31. Shirakawa, T., A. Li, M. Dubowitz, J. W. Dekker, A. E. Shaw, J. A. Faux, C. Ra, W. O. Cookson, and J. M. Hopkin. 1994. Association between atopy and variants of the β subunit of the high-affinity immunoglobulin E receptor. Nat. Genet. 7:125.
32. Perez-Villar, J. J., G. S. Whitney, M. T. Sitnick, R. J. Dunn, S. Venkatesan, K. O'Day, G. L. Schieven, T. A. Lin, and S. B. Kanner. 2002. Phosphorylation of the linker for activation of T-cells by Itk promotes recruitment of Vav. Biochemistry 41:10732.
33. Aguado, E., S. Richelme, S. Nunez-Cruz, A. Miazek, A. M. Mura, M. Richelme, X. J. Guo, D. Sainty, H. T. He, B. Malissen, et al. 2002. Induction of T helper type 2 immunity by a point mutation in the LAT adaptor. Science 296:2036.
34. Flint, J., and R. Mott. 2001. Finding the molecular basis of quantitative traits: successes and pitfalls. Nat. Rev. Genet. 2:437.
35. Morel, L., K. R. Blenman, B. P. Croker, and E. K. Wakeland. 2001. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc. Natl. Acad. Sci. USA 98:1787.
36. Podolin, P. L., P. Denny, C. J. Lord, N. J. Hill, J. A. Todd, L. B. Peterson, L. S. Wicker, and P. A. Lyons. 1997. Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1. J. Immunol. 159:1835.
37. Hattori, M., E. Yamato, N. Itoh, H. Senpuku, T. Fujisawa, M. Yoshino, M. Fukuda, E. Matsumoto, T. Toyonaga, I. Nakagawa, et al. 1999. Cutting edge: homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice. J. Immunol. 163:1721.
38. Harley, J. B., K. L. Moser, P. M. Gaffney, and T. W. Behrens. 1998. The genetics of human systemic lupus erythematosus. Curr. Opin. Immunol. 10:690.
39. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95:14863.
40. Roth, M. P., C. Viratelle, L. Dolbois, M. Delverdier, N. Borot, L. Pelletier, P. Druet, M. Clanet, and H. Coppin. 1999. A genome-wide search identifies two susceptibility loci for experimental autoimmune encephalomyelitis on rat chromosomes 4 and 10. J. Immunol. 162:1917.
41. Dahlman, I., L. Jacobsson, A. Glaser, J. C. Lorentzen, M. Andersson, H. Luthman, and T. Olsson. 1999. Genome-wide linkage analysis of chronic relapsing experimental autoimmune encephalomyelitis in the rat identifies a major susceptibility locus on chromosome 9. J. Immunol. 162:2581.
42. low CD4 T cells in rats is intrinsic to bone marrow-derived cells and is genetically controlled. J. Immunol. 166:2944.
43. Oro, A. S., T. J. Guarino, R. Driver, L. Steinman, and D. T. Umetsu. 1996. Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis. J. Allergy Clin. Immunol. 97:1402.
44. Neukirch, F., O. Lyon-Caen, M. Clanet, J. Bousquet, J. Feingold, and P. Druet. 1997. Asthma, nasal allergies, and multiple sclerosis. J. Allergy Clin. Immunol. 99:270.